Diplopia aguda postlaberintectomía química

  1. Santos Gorjón, Pablo
  2. Collazo Lorduy, Teresa
  3. Sánchez Terradillos, Elena
  4. Sánchez-Jara Sánchez, Juan Luis
  5. Velasco García, María Jesús
  6. Martín Hernández, Gonzalo
Journal:
Revista ORL

ISSN: 2444-7986,  2444-7986

Year of publication: 2012

Volume: 3

Pages: 83-94

Type: Article

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Revista ORL

Abstract

Introduction: Chemical laberinthectomy with gentamicin is an ambulatory procedure with a low rate of iatrogenical effects. We present a case with a rare complication and review the especifical literature. Clinical repport: We present a women with a left Meniere´s syndrome. A corticoid intratimpanic threathment was done and we don�t get control of symptoms. A gentamicin laberinthectomy was done, and an accute diplopia with no other clinical manifestations appears. Discussion: 95% of Ménière´s symptoms gets control with medical theathments. Security of gentamicin is accepted since 80`s decade. Susceptibility of action in inner ear is variable. We have to use minimal dosis of gentamicin to have control of the disease. Monitoring with VHIT is a new diagnosys arm to avoid complications. No references of diplopia postlaberintectomy was collected on medical literature. It´s very important control ocular movements by a recording metod or Frenzel glasses. Conclussion: Intratimpanic therapy is a secure metod. A diplopia postlaberinthectomy is undiagnosed. Usually no speciffic treathment is required. We have to use all recurses to detect a earl abolition of vestible and use minimal dose of gentamicin as possible.

Bibliographic References

  • Carranza A, Lopez I, Castellano O. Intraotic administration of gentamicin: A new method to study ototoxicity in crista ampullaris of the bullfrog. Laryngoscope 1997; 107:137-143.
  • Gibson W, Arenberg K. Pathophysiologic theories in the etiology of Méniére’s disease. Otolaryngol Clin North Am 1997; 30:961-974.
  • Herraiz C, Aparicio J. M, Plaza G. Vía intratimpánica en el tratamiento de la patología del oído interno. Acta Otorrinolaringol Esp. 2010; 61: 225-232.
  • Hirsch B, Kamerer D. Intratympanic gentamicin therapy for Meniere’s disease. Am J Otol 1997; 18:44-51.
  • Huggonier R, Huggonier S: Estrabismos, heteroforia, parálisis oculumotoras. Edic. Esp. Toray-Masson; 1973: 151/239.
  • Murofushi T, Halmagyi M, Yavor R. Intratympanic gentamicin in Meniere’s disease: Results of therapy. Am J Otol 1997; 18:52-57
  • Parnes L, Sun A, Freeman D. Corticosteroid pharmacokinetics in the inner ear: Comparison of different drugs and routes of administration. Laryngoscope 109; 7:1-17, 1999.
  • Rauch S, Oas J. Intratympanic gentamicin for treatment of intractable Méniére disease: A preliminary report. Laryngoscope 1997; 107: 49-55.
  • Sakagami M, Tomiyama S. Vascular permeability of the stria Vascularis and morphology of the endolinphatic hydrops. Ann Otol Rhinol Laryngol 1995; 104: 210-217.
  • Shea JJ Jr, Ge X. Factors influencing results with Streptomycin perfusion of the labyrinth. Am J Otol 1993; 14:570-574.
  • Takumida M, Anniko M. The effect of gentamicin on cytoskeletons in vestibular sensory cells: A high resolution scanning electron microscopic investigation. Acta Otolaryngol (Stockh) 1996; 116:817-823.
  • Wackym P, Sando I. Molecular and cellular pathology of Meniere’s disease. Otolaryngol Clin North Am 1997; 30:947-960.
Data source: Dialnet